Tango Therapeutics (TNGX) earnings, Nov 9, 2026: quarterly results
In brief
Tango Therapeutics reported on Nov 9, 2026. Earnings per share changed −379% year over year, 10.5% below the estimate; revenue −100%. The stock is now 37.5% below its 52-week high, +168.4% over 12 months. Next report: Mar 29, 2027.
EPS vs estimate−10.5%
EPS, YoY−379%
Revenue, YoY−100%
Gap · day— · —
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 13, 2026 | −7.8% | −2.5% |
| Aug 11, 2026 | −2.2% | −4.8% |
Next-quarter estimates, ratings and the TNGX chart are in the terminal.
Open the terminalFAQ
When is Tango Therapeutics's next earnings report?
Mar 29, 2027. The date comes from daily data and is corrected if the company moves it.
Did Tango Therapeutics's earnings grow?
Earnings per share fell 379% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.